On Feb 9, the latest report “Global Lung Cancer Screening Software Market 2026 by Manufacturers, Regions, Types and Applications, Forecast to 2032” from Global Info Research provides a detailed and comprehensive analysis of the global Lung Cancer Screening Software market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2026.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3444417/lung-cancer-screening-software
According to our (Global Info Research) latest study, the global Lung Cancer Screening Software market size was valued at US$ 1755 million in 2025 and is forecast to a readjusted size of US$ 5472 million by 2032 with a CAGR of 17.6% during review period.
Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.
Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.
Global Market Future Development Trends
With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.
The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an “auxiliary tool” to a “key node in the screening process.”
Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.
This report is a detailed and comprehensive analysis for global Lung Cancer Screening Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Lung Cancer Screening Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Cloud-Based、 Web-Based
Market segment by Application: Hospitals、 Medical Examination Institutions、 Public Health Screening、 Others
Major players covered: Siemens Healthineers、 GE HealthCare、 Philips Healthcare、 Canon Medical Systems、 United Imaging Healthcare、 InferVision、 Airdoc、 VUNO、 Lunit、 Qure.ai、 Riverain Technologies、 Zebra Medical Vision、 Arterys、 Deepwise、 EverFortune AI
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lung Cancer Screening Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lung Cancer Screening Software, with price, sales quantity, revenue, and global market share of Lung Cancer Screening Software from 2021 to 2026.
Chapter 3, the Lung Cancer Screening Software competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lung Cancer Screening Software breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Lung Cancer Screening Software the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Lung Cancer Screening Software sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Lung Cancer Screening Software market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lung Cancer Screening Software.
Chapter 14 and 15, to describe Lung Cancer Screening Software sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lung Cancer Screening Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
